Publication & Citation Trends
Publications
63 total
Clinical germline diagnostic exome sequencing for hereditary cancer: Findings within novel candidate genes are prevalent.
Cited by 7
Semantic Scholar
MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer OA
Cited by 47
Semantic Scholar
University of Chicago phase II consortium trial of selumetinib (MEKi) demonstrates low tolerability and efficacy in relapsed DLBCL OA
Cited by 4
Semantic Scholar
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling PDF
Cited by 167
OpenAlex
Significant and durable clinical benefit from trastuzumab in 2 patients with HER2‐amplified salivary gland cancer and a review of the literature
Cited by 39
Semantic Scholar
The influence of clinical and genetic factors on patient outcome in small cell carcinoma of the ovary, hypercalcemic type
Cited by 128
OpenAlex
MAVERICC, a phase II study of mFOLFOX6-bevacizumab (BV) vs FOLFIRI-BV as first-line (1L) chemotherapy (CT) in patients (pts) with metastatic colorectal cancer (mCRC): Outcomes by tumor location and KRAS status.
Cited by 7
Semantic Scholar
Abstract 3422: The influence of genetic and clinical factors on the outcome following a diagnosis of small cell carcinoma of the ovary, hypercalcemic type
Cited by 1
Semantic Scholar
Research Topics
Colorectal Cancer Treatments and Studies
(21)
Lung Cancer Treatments and Mutations
(10)
Cancer Treatment and Pharmacology
(10)
Lymphoma Diagnosis and Treatment
(6)
Gastric Cancer Management and Outcomes
(6)
Affiliations
Louisiana State University
Mayo Clinic
Illinois College
OSF Saint Francis Medical Center
University of Chicago